Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND USES THEREOF

No-Receipt date 2022-00317 - 01/02/2022
No-Filing date 20220400209 - 01/02/2022
No-Granting date 3109560 - 04/02/2022
No-EPO application date 16781236.1 - 23/09/2016
No-EPO granting date 3353212 - 03/11/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 2/2022 - 09/03/2022
Expiration date 24/09/2036
Kind of title Validation of European Patent
Legal status VALID
Priorities US201562222605 P23/09/2015/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07K 16/30
C07K 16/28
A61P 35/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1379485 REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROADTARRYTOWN, NY 10591-6707 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3548299 SMITH, ERIC
3548300 HABER, LAURIC
3548301 BABB, ROBERT
3548302 CHEN, GANG
3548303 MACDONALD, DOUGLAS

Representatives
CodeFirstnameSurnameAddressTownZip
745CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677

Contact
CodeFirstnameSurnameAddressTownZipCountry
2126CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677 GREECE

Owners History

Title Instruments

Payments history 10 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015